Chronic Rhinosinusitis Balloon Begins Trial
A US study is evaluating a drug-coated balloon designed to improve outcomes for chronic rhinosinusitis patients undergoing sinus surgery.
Tag: rhinosinusitis
All
Latest
Chronic Rhinosinusitis Balloon Begins Trial
A US study is evaluating a drug-coated balloon designed to improve outcomes for chronic rhinosinusitis patients undergoing sinus surgery.
Read More
Bronchiectasis + Chronic Rhinosinusitis Patients More Likely to Have P. aeruginosa in Mucus
Researchers found that patients with both bronchiectasis and chronic rhinosinusitis are more likely to test positive for Pseudomonas aeruginosa (P aeruginosa).
Read More
Airborne Toxins Trigger Unique Chronic Rhinosinusitis in Veterans
Veterans with chronic rhinosinusitis (CRS) who were exposed to burn pits and other toxins show a marked increase in sinus mast cells.
Read More
Airiver Medical Secures IDE Approval for Study of Chronic Rhinosinusitis Treatment
Airiver received investigational device exemption approval from the US FDA to begin a pivotal clinical trial of the Airiver ESSpand Sinus Drug Coated Balloon in patients with chronic rhinosinusitis.
Read More
COVID-19 Vaccination Linked to Reduced Infections in Children with Eczema
COVID-19 vaccinated children had significantly fewer infections, including pneumonia, bronchitis, bronchiolitis, sinusitis, upper respiratory infections, and more.
Read More
Aerin Medical Launches RhinAer+ Stylus for Chronic Rhinitis Relief
Aerin Medical Inc has launched RhinAer+ Stylus device for chronic rhinitis.
Read More
Tezspire Approved in EU for CRSwNP
The European Commission approved Tezspire (tezepelumab) as an add-on therapy with intranasal corticosteroids for adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP).
Read More
FDA Approves Tezspire for CRSwNP
Tezspire (tezepelumab-ekko) is now FDA-approved for chronic rhinosinusitis with nasal polyps (CRSwNP) in patients aged 12 and older.
Read More
EU Panel Recommends Tezspire for Chronic Rhinosinusitis with Nasal Polyps
AstraZeneca and Amgen’s Tezspire (tezepelumab) has been recommended for approval in the European Union (EU) for the treatment of adult patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Read More
ISS Astronauts Suffer Nasal, Sinus Problems
Sinus and congestion problems are more than just earthly annoyances, according to new research on astronauts from the International Space Station.
Read More
Clinical Practice Guideline Update for Adult Sinusitis
The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the Clinical Practice Guideline (CPG): Adult Sinusitis Update.
Read More
Mepolizumab Reduced Need for Repeat Sinus Surgeries in CRwNP Patients
Patients using mepolizumab (Nucala) experienced significant improvement in nasal polyps, nasal obstruction, smell and overall symptoms.
Read More
Tezspire Significantly Reduced Nasal Congestion, Polyp Size in CRwNP Patients
Tezspire, an add-on maintenance treatment of adult and pediatric patients aged 12 years and older with severe asthma, showed significant benefits for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) in a Phase 3 clinical trial.
Read More
FDA Approves Dupixent for Chronic Rhinosinusitis with Nasal Polyps in Adolescents
The FDA has approved Dupixent as an add-on maintenance treatment for adolescents aged 12-17 with chronic rhinosinusitis with nasal polyps, expanding its original approval for adults in 2019.
Read More
Exhalation Delivery System Improved Sinusitis Symptoms
An exhalation delivery system plus fluticasone (EDS-FLU) reduced chronic sinus infection (sinusitis) symptoms and decreased infections associated with chronic inflammation of the sinus by more than 50%.
Read MoreStudy: Dupilumab for Sinusitis in Well-Controlled Asthma
In patients with eosinophilic sinusitis and comorbid bronchial asthma, sinusitis treatment with dupilumab may ease asthma symptoms.
Read More
FDA Clears the Olympus Celeris Single-Use Sinus Debrider
The Olympus Celeris system contains the only single-use sinus debrider on the market and is indicated for cutting, coagulation, debriding and removal of thin bone and soft tissue in general ENT and sinus/rhinology procedures.
Read More
Asthma Biologics Improve Chronic Rhinosinusitis
Biologic asthma treatment improves symptoms of coexisting chronic rhinosinusitis in some patients,...
Read More
New Treatment Algorithm for Chronic Rhinosinusitis with Nasal Polyps
A new stepped-care treatment algorithm recommends Exhalation Delivery System-fluticasone (EDS-FLU) for the treatment of patients with chronic rhinosinusitis with nasal polyps.
Read More
Improving Surgical Outcomes for Chronic Rhinosinusitis: Controlling Postoperative Inflammation in the Paranasal Sinuses, including the Frontal and Maxillary
Despite improvements in surgical technique to limit tissue trauma in chronic rhinosinusitis patients, postoperative challenges can limit endoscopic sinus surgery outcomes, including scarring or stenosis of surgical opening and recurrent inflammation and polyposis.
Read MoreSelf-administered Dupixent Pen Approved for Asthma, CRSwNP
FDA approved a 300 mg single-dose pre-filled pen for Dupixent (dupilumab) to treat atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyposis (CRSwNP).
Read More
Dupixent Approved for Chronic Rhinosinusitis with Nasal Polyposis
The US FDA has approved Dupixent (dupilumab) for use with other medicines to treat chronic rhinosinusitis with nasal polyposis.
Read More
Bronchiectasis Tied to Chronic Rhinosinusitis
According to research published in the Journal of Allergy and Clinical Immunology: In Practice, 62% of bronchiectasis patients suffer from chronic rhinosinusitis.
Read More